Literature DB >> 14522365

Inhibitory capacity of different steroids on neutrophil migration across a bilayer of endothelial and bronchial epithelial cells.

Frans J van Overveld1, Urszula A Demkow, Dorota Górecka, Jan Zielinski, Wilfried A De Backer.   

Abstract

Neutrophil infiltration to the airway lumen is a common feature of respiratory inflammatory processes. The aim of this study was to evaluate whether different corticosteroids exert any selective effect on the migration of isolated neutrophils. A bilayer of cultured human endothelial and bronchial epithelial cells was used as a model for neutrophil migration through the blood-air barrier. Low spontaneous migration of neutrophils (2.8+/-0.9%, n=8; mean+/-S.E.M.) occurred, while in the absence of any steroid, a migration of 28.5+/-7.6% could be induced by lipopolysaccharide. Pre-incubation during 1 h of epithelial cells with dexamethasone, budesonide, or prednisolone (10(-10)-10(-4) M) showed in all instances a concentration-dependent inhibition following a bell-shaped curve. At 10(-7) M, both dexamethasone and budesonide were on the minimum effect peak of the bell-shaped curve. The peak for prednisolone was found at 10(-8) M. However, when steroid pre-incubation was extended to 4 h, a sigmoid curve was observed, with significant inhibition of migration at concentrations >10(-7) M. Steroids can inhibit neutrophil recruitment through two different pathways with distinct result, depending on the length of incubation time.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522365     DOI: 10.1016/s0014-2999(03)02153-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia.

Authors:  Dennis Chen; Marcos I Restrepo; Michael J Fine; Mary Jo V Pugh; Antonio Anzueto; Mark L Metersky; Brandy Nakashima; Chester Good; Eric M Mortensen
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

Review 2.  Host-pathogen interplay in the respiratory environment of cystic fibrosis.

Authors:  Lael M Yonker; Cristina Cigana; Bryan P Hurley; Alessandra Bragonzi
Journal:  J Cyst Fibros       Date:  2015-03-19       Impact factor: 5.482

3.  Dysregulated Neutrophil Phenotype and Function in Hospitalised Non-ICU COVID-19 Pneumonia.

Authors:  Kylie B R Belchamber; Onn S Thein; Jon Hazeldine; Frances S Grudzinska; Aduragbemi A Faniyi; Michael J Hughes; Alice E Jasper; Kay Por Yip; Louise E Crowley; Sebastian T Lugg; Elizabeth Sapey; Dhruv Parekh; David R Thickett; Aaron Scott
Journal:  Cells       Date:  2022-09-16       Impact factor: 7.666

4.  Relationship between the use of inhaled steroids for chronic respiratory diseases and early outcomes in community-acquired pneumonia.

Authors:  Jordi Almirall; Ignasi Bolíbar; Mateu Serra-Prat; Elisabet Palomera; Jordi Roig; Imma Hospital; Eugenia Carandell; Mercè Agustí; Pilar Ayuso; Andreu Estela; Antoni Torres
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

5.  Dissociation between systemic and pulmonary anti-inflammatory effects of dexamethasone in humans.

Authors:  Johann Bartko; Leopold Stiebellehner; Ulla Derhaschnig; Christian Schoergenhofer; Michael Schwameis; Helmut Prosch; Bernd Jilma
Journal:  Br J Clin Pharmacol       Date:  2016-01-15       Impact factor: 4.335

6.  Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense.

Authors:  Kathleen Smoak; Jennifer Madenspacher; Samithamby Jeyaseelan; Belinda Williams; Darlene Dixon; Katie R Poch; Jerry A Nick; G Scott Worthen; Michael B Fessler
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.